Clinical Trials | CHOP Research Institute
 

Clinical Trials

Dr. Aboian's research focus is to identify imaging biomarkers in neuro-oncology. Her training and clinical experience focused on neuroimaging of primary brain tumors and metastatic cancer to the brain with dedicated subspecialty training in neuroradiology and nuclear medicine.

E-mail:
aboianm [at] chop.edu

In the Chan lab, we are motivated by our belief that no child should die from a preventable cause. To advance our shared goal, our work is rooted in rigorous science while cultivating a culture of intellectual curiosity, collaboration, and innovation.

Published on
Jan 6, 2025
The CHOP-led trial showed that blinatumomab plus chemotherapy drastically improved survival rates for patients with B-ALL.

The CHOP Kidney Stone Frontier Program integrates multidisciplinary clinical expertise in urology and nephrology with advanced multi-omics research to develop new diagnostic tests that will transform the management of children and adolescents with kidney stone disease.

The purpose of this study is to find out if the study drug, Obinutuzumab, is effective in achieving a complete renal response for adolescents with active class III or IV lupus nephritis.

Research Family Partners assists study teams with community engagement and incorporating the patient and family voice in research.

Published on
Jul 12, 2024
Subecha “Suvy” Dahal shares how she discovered a natural inclination for creating whimsical oil paintings.
Published on
Jun 20, 2024
Using CRISPR/Cas9 gene editing in an early-stage clinical trial, researchers showed improved vision for a severe inherited form of blindness.
Published on
Jun 3, 2024
The CHOP-Penn Autism Research Symposium explored opportunities for breakthroughs in the understanding and treatment of autism spectrum disorder.
Published on
May 29, 2024
Decades ago, Katherine A. High, MD, and colleagues began an unprecedented journey to develop a new kind of treatment for hemophilia B.